Efficacy and Safety of Danirixin (GSK1325756) Co-administered With Standard-of-Care Antiviral (Oseltamivir): A Phase 2b, Global, Randomized Study of Adults Hospitalized With Influenza
出版年份 2019 全文链接
标题
Efficacy and Safety of Danirixin (GSK1325756) Co-administered With Standard-of-Care Antiviral (Oseltamivir): A Phase 2b, Global, Randomized Study of Adults Hospitalized With Influenza
作者
关键词
-
出版物
Open Forum Infectious Diseases
Volume 6, Issue 4, Pages -
出版商
Oxford University Press (OUP)
发表日期
2019-04-03
DOI
10.1093/ofid/ofz163
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapeutically Attenuating Neutrophil Recruitment with a CXCR2 Antagonist in Combination with Oseltamivir Ameliorates Influenza Induced Lung Injury and Disease
- (2019) Michael L Washburn et al. Open Forum Infectious Diseases
- Effect of the CXCR2 antagonist danirixin on symptoms and health status in COPD
- (2018) Aili L. Lazaar et al. EUROPEAN RESPIRATORY JOURNAL
- Danirixin: A Reversible and Selective Antagonist of the CXC Chemokine Receptor 2
- (2017) Jakob Busch-Petersen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial
- (2017) Francisco M Marty et al. Lancet Respiratory Medicine
- Update: Influenza Activity in the United States During the 2016–17 Season and Composition of the 2017–18 Influenza Vaccine
- (2017) Lenee Blanton et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection—United States, 2005–2008
- (2015) Shikha Garg et al. BMC INFECTIOUS DISEASES
- The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functions
- (2015) Stipo Jurcevic et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjects
- (2015) Bruce E. Miller et al. BMC Pharmacology & Toxicology
- Evaluation of Intravenous Peramivir for Treatment of Influenza in Hospitalized Patients
- (2014) M. D. de Jong et al. CLINICAL INFECTIOUS DISEASES
- The pharmacokinetics of conventional and bioenhanced tablet formulations of danirixin (GSK1325756) following oral administration in healthy, elderly, human volunteers
- (2014) Bruce E. Miller et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments
- (2014) T. Jefferson et al. BMJ-British Medical Journal
- Pathogenesis of influenza-induced acute respiratory distress syndrome
- (2013) Kirsty R Short et al. LANCET INFECTIOUS DISEASES
- Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis
- (2012) Richard B. Moss et al. Journal of Cystic Fibrosis
- Excessive Neutrophils and Neutrophil Extracellular Traps Contribute to Acute Lung Injury of Influenza Pneumonitis
- (2011) Teluguakula Narasaraju et al. AMERICAN JOURNAL OF PATHOLOGY
- Outcomes of adults hospitalised with severe influenza
- (2010) N. Lee et al. THORAX
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now